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Aim. To predict protein networks which may comprise the β subunit of the translation elongation complex 
eEF1B in lung carcinoma cell line. Methods. The protein partners of eEF1Bβ from cytoplasmic extract of 
A549 cells were identified by co-immunoprecipitation (co-IP) combined with liquid chromatography-tandem 
mass spectrometry (LC-MS/MS). The molecular interaction network for eEF1Bβ was predicted and visual-
ized by a Cytoscape 3.2.0 program using an MCODE plugin. GO analysis of cellular distribution was per-
formed by a STRAP program. Results. 162 high-scored proteins interacting with eEF1Bβ in the cytoplasm of 
lung carcinoma cells A549 have been identified by mass-spectrometry. Possible functional networks involving 
these contacts were predicted bioinformatically. Conclusions. Four protein networks are identified as possible 
targets of eEF1Bβ in lung cancer cells. These groups are involved in the cell cycle regulation; DNA replication 
and repair; chromatin remodeling; chaperoning and signal transduction. The data allow to narrow down further 
search for non-canonical cancer-related function of eEF1Bβ.
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Introduction
The human translation elongation machinery is re-
sponsible for the elongation of a polypeptide chain 
by the 80S ribosome. The multisubunit complex 
eEF1B provides nucleotide exchange in the eEF1A 
molecule. The latter, being in GTP form, supplies 
aminoacyl-tRNA to the ribosomal A site. Correct 
codon-anticodon recognition persuades the GTP hy-
drolysis, after which eEF1A*GDP leaves the ribo-
some for another round of the GDP/GTP exchange. 
eEF1B comprises three subunits, among which 
eEF1Bα and eEF1Bβ are functional whereas a role 
of eEF1Bγ is not yet deciphered.
For a long time the eEF1B complex was consi-
dered very stable, however, recently we have found 
that some pool of its subunits could exist separately 
from the complex in different human cancer tissues 
[1–3]. The role of non-complexed subunits remains 
elusive. Few studies have suggested that eEF1Bβ 
may play a role in carcinogenesis, by currently un-
known means [4–7]. Some non-canonical duties of 
eEF1Bβ have been revealed recently [8–10]. We rea-
son that eEF1Bβ, either involved in eEF1B or not, 
may stably or transiently join other protein comple-
xes, fulfilling in such way its cancer-related func-
tions. One of the ways to approach these functions is 
the identification of non-translational contacts of the 
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eEF1B subunits in the cancer cell. Here, we present 
the combination of our experimental and bioinfor-
matics data permitting to predict for the first time 
possible non-translational interaction networks of 
the eEF1Bβ subunit in the cytoplasm of lung carci-
noma cells A549.
Materials and Methods
Obtaining cytoplasmic fraction
A549 cells were cultured in DMEM (Sigma, USA) 
growth medium with 10% FBS (Sigma, USA) and 
1 % penicillin/streptomycin (Sigma). The cells were 
grown up to 7×106 cells/ml and harvested with 
Trypsin-EDTA. Cytoplasmic and nuclear fractions 
were obtained as described in [11] with modifica-
tions. The cells were resuspended in 1.5 volume of 
lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 
0.5 % NP-40, 0.2 mM PMSF, 0.5 mM DTT) and in-
cubated on ice for 20 min. The suspended cells were 
centrifuged at 400 g for 10 min following with su-
pernatant centrifugation at 16000 g for 30 min. The 
obtained fraction was used as cytoplasmic extract. 
The quality of the cytoplasmic fraction was analyzed 
by Western blot with primary mouse anti-Tubulin 
(cytoplasmic marker) and rabbit anti-PARP and anti-
Histone 3.3 (nuclear markers) antibodies.
Co-immunoprecipitation
The cytoplasmic extract from A549 cells was incu-
bated with Protein G Sepharose (Sigma, USA) for 
1 hour at 4 °C for pre-clearing. Mouse anti-eEF1Bβ 
antibodies (Abnova, Taiwan) (1.5 μg of antibodies 
per 1 mg of total protein) were added to pre-cleared 
lysates and the incubation persisted overnight at 
4 °C. To precipitate the antibody-protein complex, 
Protein G Sepharose was added according to the 
manufacturer’s protocol and incubated for 2 hours at 
4 °C. All incubations have been done with orbital 
shaker. The samples were analyzed by 12 % PAGE 
analysis. Gel was stained with the colloidal 
CBB-G250 [12]. The protein bands of interest were 
cut and processed for mass-spectrometry analysis 
(LC-MS/MS). 
LC-MS/MS
The cytoplasmic extract incubated just with 
G-Sepharose was used as a control of nonspecific 
binding. Only the bands that were not present in the 
control or were much more extensive than in the 
control were cut and processed for mass spectrome-
try analysis at the Mass Spectrometry Laboratory of 
the Institute of Biochemistry and Biophysics 
(Warsaw, Poland). The proteins from each band were 
digested with trypsin. MS analysis was performed 
using a LTQ-Orbitrap Velos mass spectrometer 
(Thermo Scientific) coupled with a nanoAcquity 
(Waters Corporation) LC system. Spectrometer pa-
rameters were as follows: polarity mode, positive; 
capillary voltage, 1.5 kV. A sample was first applied 
to the nanoACQUITY UPLC Trapping Column 
(Waters) using water containing 0.1 % formic acid 
as the mobile phase. Next, the peptide mixture was 
transferred to the nanoACQUITY UPLC BEH C18 
Column (Waters, 75 μm inner diameter; 250 mm 
long) and an ACN gradient (5–40% over 100 min) 
was applied in the presence of 0.1 % formic acid 
with a flow rate of 250 nl/min and eluted directly to 
the ion source of the mass spectrometer. Each LC 
run was preceded by a blank run to avoid sample 
carry-over between the analyses.
The acquired MS/MS data were pre-processed 
with Mascot Distiller (version 2.3.2.0, Matrix 
Science, London, UK). The initial search parameters 
were set as follows: enzyme, trypsin; variable modi-
fications, carbamidomethyl, oxidation; peptide mass 
tolerance, ± 100 ppm; fragment mass tolerance, ± 
0.1 Da; max missed cleavages, 1; ions score or ex-
pect cut-off, 30; max missed cleavages – 1, Swiss-
Prot database with the taxonomy restricted to Homo 
sapiens (20348 sequences); fragmentation mode, 
HCD; significance threshold, p<0.05. 
Bioinformatic analysis
To find and visualize the molecular interaction net-
work for eEF1Bβ we used Cytoscape 3.2.0 Program. 
Cytoscape3.2.0 is a new powerful open source bio-
informatics software platform for visualizing mo-
lecular interaction networks and integrating with 
349
Non-canonical interactions of eEF1Bβ
gene expression profiles and other state data [13]. 
The Cytoscape 3.2.0 interaction database BIOGRID 
was supplemented with newly identified protein 
partners of eEF1Bβ and analyzed by MCODE plu-
gin which finds clusters (highly interconnected re-
gions) in any network loaded into Cytoscape. 
Clusters in a protein-protein interaction network 
have been shown to be protein complexes and parts 
of pathways [14].
For the sake of clarity, such known protein part-
ners of eEF1Bβ as eEF1A1, eEF1A2 and UBC 
(polyubiquitin-C) were excluded from the database 
as they interact with a huge number of cell proteins 
and create a very complicated network of protein-
protein interactions that is not associated with 
eEF1Bβ directly. As the Human BioGRID Database 
(18107 proteins, 217927 protein interactions) was 
too huge for analysis by MCODE program, we sim-
plified the task by taking for analysis only the first 
(direct) partners of eEF1Bβ partners. 
MCODE analysis was performed on the hybrid 
supercomputer “SCIT-4” of the Glushkov Institute 
of Cybernetics (GIC) of National Academy of 
Sciences of Ukraine (http://icybcluster.org.ua).
Cellular component GO analysis of proteins in 
cluster (complex) containing eEF1Bβ was per-
formed by STRAP (Software Tool for Researching 
Annotation of Proteins) Program [15].
Results and Discussion
The aim of this study was to identify protein partners 
of eEF1Bβ in the cytoplasmic fraction of A549 cells 
and to place them in the context of known protein 
networks in order to decipher possible novel func-
tional routes of the eEF1B complex/free eEF1Bβ 
subunit in the cytoplasm of cancer cells. For identifi-
cation of possible partners of eEF1Bβ we used the 
method of co-immunoprecipitation, with subsequent 
mass-spectrometric identification of the interacting 
proteins. 162 proteins were identified as the interact-
ing partners of eEF1Bβ as described in Materials 
and Methods section. 
First, we used the existing human BioGRID data-
base to generate by MCODE the protein network 
containing eEF1Bβ as a target partner. The resulting 
network contained 35 proteins. Two of them showed 
direct interactions with eEF1Bβ (Fig. 1). Those are 
eEF1Bγ and FLNC (filamin C, gamma) and through 
them eEF1Bβ is connected with other functional 
groups. There were six evident protein groups that 
represent G-proteins (GNAl1, GNAl2, GNB4 – sub-
cluster A) connected with melatonin receptor 1A; 
mRNA processing (CSTF2, CPSF2 – subcluster B); 
transcription regulation (TAF1, TAF2, TBP, 
RANBP2, HIST1H4A, TBL1X – subcluster C); sig-
nal transduction (CCND3, CHUK, PPP1CA, 
PPP1CB, IKBKB, CTNNB1, UBE2D1, NPEPPS, 
RYK, SLC9A3R1 – subcluster D); cell cycle regula-
tion (BTG1, FBXL3, FBXW2, BTG2 – subcluster 
E); and desmosomal cadherin-plakoglobin complex 
(CSTA, IVL, DSP, JUP – subcluster F) (Fig. 1). 
Then, to show yet unknown networking clusters 
of eEF1Bβ we supplemented the BioGRID database 
with newly discovered interacting partners of 
eEF1Bβ, identified by us in co-IP/MS experiments 
and performed the same analysis by the Cytoscape 
3.2.0 program. The resulting protein cluster con-
tained 71 proteins and showed different organization 
(Fig. 2; Table 1). It was possible to differentiate sev-
eral functional protein groups among the main clus-
ter (Fig. 2). The proteins of these subclusters partici-
pate in the translation (aminoacyl-tRNA synthetases 
IARS, RARS, MARS – subcluster A); chaperoning 
and signal transduction (DNAJA1, HSPA1A, 
HSPA1B, HSPA8, YWHAB, YWHAQ, PRKDC, 
CDK4 – subcluster B); mRNA processing (SRSF2, 
SRSF3, SON, U2AF1 – subcluster C); transcription 
regulation (PHC1, PHC2, PHC3, CBX4 – subclus-
ter D); cell cycle regulation (ANAPC2, ANAPC5, 
ANAPC7, APC2, CDC16, CDC23, CDC26, 
BUB1B, TRIM33 – subcluster E); gene expression 
regulation and chromatin remodeling (HDAC1, 
MBD2, NCOR2, IRF5, TOP2B, PIAS1, SP1, 
BCL11B, JUN, HIST3H3, ARID1A, ARID1B, 
SMARCD1, SMARCD2, SMARCE 1, MORF4L2, 
MRGBP – subcluster F); DNA replication and repair 
(ORC4, ORC5, ORC6, DBF4, MCM7, TONSL, 
MMS22L – subcluster G) (Fig. 2). There are some 
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Fig. 1. Protein cluster con-
taining eEF1Bβ generated by 
MCODE in Cytoscape 3.2.0. 
Program from Human Bi-
aoGRID database. (Subclus-
ters: A – G-proteins, B – 
mRNA processing, C – tran-
scription regulation, D – sig-
nal transduction, E – cell cy-
cle regulation, F – des mo so mal 
cadherin-plakoglobin com-
plex).
Fig. 2. Protein cluster con-
taining eEF1Bβ (Gene ID 
1936) generated by MCODE 
in Cytoscape 3.2.0. Program 
from Human BioGRID data-
base supplemented with 
co-IP/MS experimental data. 
(Subclusters: A – translation 
related proteins, B – chape ro-
nes and signal transduction 
associated proteins, C – 
mRNA proces sing, D – tran-
scription regulation, E – cell 
cycle regulation, F – gene ex-
pression regulation and chro-
matin remo deling, G – DNA 
replication and repair).
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Table 1. Proteins of the eEF1Bβ cluster generated by MCODE after adding to BioGRID database  
experimental co-I P/MS results. 
№ Entry name Gene names Protein names
Localization 
[of]
Cyto Nucl
Subclaster
(according 
[to] Fig. 2)
1 1433B YWHAB 14-3-3 protein beta/alpha + + B
2 1433T YWHAQ 14-3-3 protein theta + B
3 APC2 APC2 APCL Adenomatous polyposis coli protein 2 + + E
4 ANC2 ANAPC2 APC2 KIAA1406 Anaphase-promoting complex subunit 2 (APC2) + + E
5 APC5 ANAPC5 APC5 Anaphase-promoting complex subunit 5 (APC5) + + E
6 APC7 ANAPC7 APC7 Anaphase-promoting complex subunit 7 (APC7) + + E
7 SYRC RARS Arginine--tRNA ligase, cytoplasmic + + A
8 ARI1A 
ARID1A BAF250 
BAF250A C1orf4 
OSA1 SMARCF1
AT-rich interactive domain-containing protein 1A + F
9 ARI1B 
ARID1B BAF250B 
DAN15 KIAA1235 
OSA2
AT-rich interactive domain-containing protein 1B + + F
10 BC11B Bcl11b Ctip2 Rit1 B-cell lymphoma/leukemia 11B + F
11 CDC16 CDC16 ANAPC6 Cell division cycle protein 16 homolog + + E
12 CDC23 CDC23 ANAPC8 Cell division cycle protein 23 homolog + + E
13 CDC26 CDC26 ANAPC12 Cell division cycle protein 26 homolog + + E
14 CDK4 CDK4 Cyclin-dependent kinase 4 + + B
15 MCM7 MCM7 CDC47 MCM2 DNA replication licensing factor MCM7 + + G
16 TOP2B TOP2B DNA topoisomerase 2-beta + + F
17 PRKDC PRKDC HYRC HYRC1 DNA-dependent protein kinase catalytic subunit + + B
18 DNJA1 DNAJA1 DNAJ2 
HDJ2 HSJ2 HSPF4
DnaJ homolog subfamily A member 1 + + B
19 CBX4 CBX4 E3 SUMO-protein ligase CBX4 + D
20 PIAS1 PIAS1 DDXBP1 E3 SUMO-protein ligase PIAS1 + F
21 RBX1 RBX1 RNF75 ROC1 E3 ubiquitin-protein ligase RBX1 + +
22 RN185 RNF185 E3 ubiquitin-protein ligase RNF185
23 TRI33 TRIM33 KIAA1113 RFG7 TIF1G E3 ubiquitin-protein ligase TRIM33 + E
24 EF1D EEF1D EF1D Elongation factor 1-delta + + A
25 FBX25 FBXO25 FBX25 F-box only protein 25 +
26 HS71A HSPA1A HSPA1 HSX70 Heat shock 70 kDa protein 1A + + B
27 HS71B HSPA1B Heat shock 70 kDa protein 1B + + B
28 HSP7C HSPA8 HSC70 HSP73 HSPA10 Heat shock cognate 71 kDa protein + + B
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№ Entry name Gene names Protein names
Localization 
[of]
Cyto Nucl
Subclaster
(according 
[to] Fig. 2)
29 HNRPC HNRNPC HNRPC Heterogeneous nuclear ribonucleoproteins + +
30 HDAC1 HDAC1 RPD3L1 Histone deacetylase 1 + + F
31 H31T HIST3H3 H3FT Histone H3.1t + F
32 IRF5 IRF5 Interferon regulatory factor 5 + + F
33 SYIC IARS Isoleucine--tRNA ligase, cytoplasmic + + A
34 K1C9 KRT9 Keratin, type I cytoskeletal 9 +
35 KINH KIF5B KNS KNS1 Kinesin-1 heavy chain + +
36 MBD2 MBD2 Methyl-CpG-binding domain protein 2 + + F
37 BUB1B BUB1B BUBR1 MAD3L SSK1
Mitotic checkpoint serine/threonine-protein 
kinase BUB1 beta + + E
38 MO4L2 MORF4L2 KIAA0026 MRGX Mortality factor 4-like protein 2 + F
39 MRGBP MRGBP C20orf20 MRG/MORF4L-binding protein + F
40 NCOA2 NCOA2 BHLHE75 SRC2 TIF2 Nuclear receptor coactivator 2 +
41 NCOR2 NCOR2 CTG26 Nuclear receptor corepressor 2 + + F
42 ORC4 ORC4 ORC4L Origin recognition complex subunit 4 + + G
43 ORC5 ORC5 ORC5L Origin recognition complex subunit 5 + G
44 ORC6 ORC6 ORC6L Origin recognition complex subunit 6 + G
45 PHF10 PHF10 BAF45A PHD finger protein 10 +
46 PHC1 PHC1 EDR1 PH1 Polyhomeotic-like protein 1 + D
47 PHC2 PHC2 EDR2 PH2 Polyhomeotic-like protein 2 + D
48 PHC3 PHC3 EDR3 PH3 Polyhomeotic-like protein 3 + D
49 UBB UBB Polyubiquitin-B + +
50 ANM1 PRMT1 HMT2 HRMT1L2 IR1B4 Protein arginine N-methyltransferase 1 + +
51 DBF4A DBF4 ASK DBF4A ZDBF1 Protein DBF4 homolog A + G
52 MMS22 MMS22L C6orf167 Protein MMS22-like + G
53 SON 
SON C21orf50 DBP5 
KIAA1019 NREBP 
HSPC310 HSPC312
Protein SON + C
54 F86B2 FAM86B2 Putative protein N-methyltransferase FAM86B2
55 RL1D1 RSL1D1 CATX11 CSIG PBK1 L12 Ribosomal L1 domain-containing protein 1 +
56 RBM14 RBM14 SIP RNA-binding protein 14 +
57 RBM39 RBM39 HCC1 RNPC2 RNA-binding protein 39 +
58 RALY RALY HNRPCL2 P542 RNA-binding protein Raly +
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ubiquitination related proteins that work mostly as 
connecting links between the subclusters (UBE2D1, 
RBX1, UBB, UBASH3B, FBXO25). 
Interestingly, the only one protein (except 
eEF1Bβ) was common for the cluster obtained from 
Human BioGRID database supplemented with co-
IP/MS experimental data and the cluster obtained 
from only BioGRID database. It is ubiquitin-conju-
gating enzyme E2 D1 (UBE2D1), a member of the 
E2 ubiquitin-conjugating enzyme family. It partici-
pates in the ubiquitination of the tumor-suppressor 
protein p53 and the hypoxia-inducible transcription 
factor HIF1 alpha by interacting with the E1 ubiqui-
tin-activating enzyme and the E3 ubiquitin-protein 
ligases. Therefore, it is possible that a eEF1Bβ takes 
part in the cell signaling events where p53 and/or 
HIF1 are involved.
Peculiarly, the only 4 out of 162 novel protein in-
teractions were automatically selected by the 
Cytoscape program to build reliable protein net-
works, those are isoleucyl-tRNA synthetase (IARS); 
protein arginine methyltransferase 1 (PRMT1); DnaJ 
(Hsp40) homolog, subfamily A, member 1 
(DNAJA1) and tubulin alpha 1c (TUBA1C). This 
fact may reflect the limitations of the current version 
of the Cytoscape program. At the same time we can-
not exclude that these proteins demonstrated the 
strongest networking ability among the 162 partners. 
Isoleucine-tRNA synthetase (Gene ID 3376) is 
the class-I aminoacyl-tRNA synthetase which cata-
lyzes the aminoacylation of tRNAIle by isoleucine. It 
belongs to the translation related proteins subclus-
ter A (Fig. 2.). Despite eEF1Bβ was shown to inter-
act with several aminoacyl-tRNA syhthetases, the 
№ Entry name Gene names Protein names
Localization 
[of]
Cyto Nucl
Subclaster
(according 
[to] Fig. 2)
59 SRSF2 SRSF2 SFRS2 Serine/arginine-rich splicing factor 2 + C
60 SRSF3 SRSF3 SFRS3 SRP20 Serine/arginine-rich splicing factor 3 + + C
61 U2AF1 U2AF1 U2AF35 U2AFBP FP793 Splicing factor U2AF 35 kDa subunit + C
62 SLAP2 SLA2 C20orf156 SLAP2 Src-like-adapter 2 +
63 SMRD1 SMARCD1 BAF60A
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily D 
member 1 
+ F
64 SMRD2 SMARCD2 BAF60B PRO2451
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily D 
member 2 
+ F
65 SMCE1 SMARCE1 BAF57
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily E 
member 1 
+ F
66 TCPG CCT3 CCTG TRIC5 T-complex protein 1 subunit gamma +
67 TONSL TONSL IKBR NFKBIL2 Tonsoku-like protein + G
68 JUN JUN Transcription factor AP-1 + + F
69 SP1 SP1 TSFP1 Transcription factor Sp1 + + F
70 TBA1C TUBA1C TUBA6 Tubulin alpha-1C chain + +
71 UB2D1 UBE2D1 SFT UBC5A UBCH5 UBCH5A Ubiquitin-conjugating enzyme E2 D1 + +
In bold – experimentally identified partners.
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valyl-tRNA synthetase being a the most prominent 
example [16, 17], no interaction with isoleucyl-
tRNA syhthetase was shown before. In the case this 
interaction is confirmed by other experimental 
means, it may shed a light on the novel structural 
feature of the organization of translation compart-
ment in human cells. Interestingly, the translation-
related subcluster comprised both several tRNA syn-
thetases (IARS, RARS, MARS) and eEF1Bβ itself, 
the latter observation favors a possibility of forming 
eEF1Bβ oligomers [18].
Peculiar is the existence of a direct contact of 
eEF1Bβ with the protein arginine methyltransfe-
rase 1 (PRMT1) (Fig. 2). This protein (Gene ID 
3276) in our scheme does not belong to any group, 
rather it serves as a connection link among three sub-
clusters – translation related proteins (A), gene ex-
pression regulation and chromatin remodeling (F) 
and DNA replication and repair (G). PRMT1 might 
potentially methylate one of 16 arginine residues of 
eEF1Bβ. Amino acid sequence of eEF1Bβ was ana-
lyzed by GPS-MSP (Methyl-group Specific 
Predictor) 1.0 Program [19]. Indeed, arginine 123 
(R123) was predicted as a potential methylation site 
with a rather high score. No arginine methylation 
sites were predicted in eEF1Bα and eEF1Bγ, which, 
together with eEF1Bβ, constitute the eEF1B com-
plex. Thus, the interaction with PRMT1 could be 
important for methylation of R123 in eEF1Bβ. 
PRMT1 is known to be responsible for the majority 
of cellular arginine methylation activity [20]. 
Moreover, its disregulated expression may play a 
role in many types of cancer [21]. Recently it has 
been shown that PRMT1 is an important regulator of 
epithelial-mesenchymal transition (EMT), cancer 
cell migration, and invasion in non-small cell lung 
cancer [22]. On the other hand, there is an evidence 
that eEF1Bβ can participate in modulation of prolif-
eration and EMT in cancer cells [23]. Taking into 
consideration these facts, a possibility of synergic 
action of eEF1Bβ and PRMT1 in cancerogenesis 
may be suggested.
Alpha tubulin TUBA1C has GTP-binding activi-
ty. GTP hydrolysis may inhibit microtubule nucle-
ation by destabilizing the nascent plus ends required 
for persistent elongation. Interestingly, eEF1Bβ is a 
GDP/GTP exchange factor. Among TUBA1C-
related pathways are transport to the Golgi and sub-
sequent modification. This protein is also a partner 
of eEF1A1, which we excluded from the input data; 
therefore, we can suggest that eEF1Bβ interacts with 
TUBA1C together with eEF1A1. In the cluster 
(Fig. 2) TUBA 1C (Gene ID 84790) connects trans-
lation related subcluster (A) and chaperones and sig-
nal transduction associated subcluster (B).
DNAJA1 (Gene ID 3301) is a co-chaperone for 
chaperones HSPA8/Hsc70, HSPA1A and HSPA1B 
which all are present in the corresponding subcluster 
(B) (Fig.2). It stimulates ATP hydrolysis, but not the 
folding of unfolded proteins mediated by HSPA1A. 
Recently, eEF1A1/HSC70 have been shown to co-
operatively suppress brain endothelial cell apopto-
sis [24]. Hsp70 and eEF1A1 interacted with HSP23 
under calcium overload, showing anti-apoptotic ef-
fects [25]. It cannot be excluded that interaction of 
eEF1Bβ with DNAJA1 can bring to this co-chaper-
one another co-chaperone eEF1A1, with subsequent 
inhibition of apoptosis in cancer cells. Thus, the ex-
perimentally determined contacts of both TUBA1C 
and DNAJA1 with eEF1Bβ may be accomplished 
either directly or via eEF1A. 
Several protein networks (B, E, F and G) (Fig. 2.) 
were identified as possible targets of eEF1Bβ in can-
cer as they contain the proteins associated with car-
cinogenesis. 
NCOR2 (Gene ID 9612) is a nuclear receptor co-
repressor 2 that mediates transcriptional silencing of 
certain target genes and is localized in the gene expres-
sion regulation and chromatin remodeling subcluster F 
(Fig. 2). It is a member of the family of thyroid hor-
mone- and retinoic acid receptor-associated co-repres-
sors. This protein acts as part of a multisubunit com-
plex, which includes histone deacetylases to modify 
chromatin structure that prevents the basal transcrip-
tional activity of target genes. Aberrant expression of 
NCOR2 is associated with certain cancers [26]. 
JUN, jun proto-oncogene, (Gene ID 3725) is a di-
rect partner of NCOR2 and is localized in the same 
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subcluster F (Fig. 2). This protein is highly similar to 
the viral protein and interacts directly with the spe-
cific target DNA sequences to regulate the gene ex-
pression. Its gene is intronless and is mapped to a 
chromosomal region involved in both translocations 
and deletions in human malignancies. In the study 
using non-small cell lung cancers (NSCLC), JUN 
was found to be overexpressed in 31 % of the cases 
in the primary and metastatic lung tumors, whereas 
no JUN expression was observed in the normal con-
ducting airway and alveolar epithelia [27].
BUB1B (BUB1 mitotic checkpoint serine/threo-
nine kinase B) is a kinase involved in the spindle 
checkpoint function. BUB1B (Gene ID 701) belongs 
to the cell cycle regulation subclaster E and is a di-
rect partner of NCOR2 (Fig. 2). The protein is loca-
lized at the kinetochore and plays a role in the inhibi-
tion of the anaphase-promoting complex/cyclosome 
(APC/C), delaying the onset of anaphase and ensu-
ring proper chromosome segregation. It may play a 
role in tumor suppression [28].
 MMS22L, (MMS22-like, DNA repair protein) 
(Gene ID 253714) is localized in the DNA replica-
tion and repair subcluster G (Fig. 2). It forms a com-
plex with tonsoku-like, DNA repair protein 
(TONSL). This complex recognizes and repairs 
DNA double-strand breaks at the sites of stalled or 
collapsed replication forks. It can also bind the his-
tone-associated protein NFKBIL2 to help to regulate 
the chromatin state at the stalled replication forks. 
Finally, this protein appears to be overexpressed in 
the most lung and esophageal cancers [29]. 
CDK4, cyclin-dependent kinase 4, (Gene ID 
1019) is a member of the chaperones and signal 
transduction associated subcluster B (Fig. 2). It be-
longs to the Ser/Thr protein kinase family. CDK4 is 
a catalytic subunit of the protein kinase complex that 
is important for [the] cell cycle G1 phase progres-
sion. The activity of this kinase is restricted to the 
G1-S phase, which is controlled by the regulatory 
subunits D-type cyclins and CDK inhibitor p16 
(INK4a). This kinase is responsible for the phos-
phorylation of retinoblastoma gene product (Rb). 
Altered expression or functioning of CDK4 was 
found to be associated with tumorigenesis of a vari-
ety of cancers [30]. On the other hand, there are 
some evidences that eEF1Bβ signaling pathway 
leads to the modulation of cancer cells proliferation 
Go Term
Fig. 3. Cellular component GO analysis of proteins in cluster (complex) containing eEF1Bβ.
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via cyclin D1. It was shown that eEF1Bβ knock-
down in cancer cells significantly decreased the cell 
cycling and proliferation, which were concomitant 
with a decrease in the cyclin D1 expression and RB 
phosphorylation [23].
 To classify the proteins involved into eEF1Bβ 
networking by the subcellular localization we ap-
plied the GO analysis using the STRAP program 
(Fig. 3). The proteins were mainly localized to the 
nucleus (66 proteins) and cytoplasm (40 proteins), 
whereas 37 of them can be found in both cytoplasm 
and nucleus, and protein eEF1Bβ is among them 
(Table1). Interestingly, despite our “cyto-nucleo” 
fractionation was well controlled, some proteins 
considered by databases to be nuclear were detect-
ed among the cytoplasmic partners. It reinforces 
the recent observations that many proteins believed 
to be nuclear show cytoplasmic and/or organelle 
localization as well. There were also 20 proteins as-
sociated with chromosomes, 14 proteins with cyto-
skeleton, 6 proteins with plasma membrane, 4 with 
mitochondria, 3 with endoplasmic reticulum and 3 
with endosome (Fig.3). 
Conclusions
162 proteins interacting with eEF1Bβ in the cytoplasm 
of human cancer cells have been used to construct pos-
sible functional networks involving these contacts by 
the Cytoscape 3.2.0 and STRAP programs. 
Four protein networks are identified as possible 
targets of eEF1Bβ in cancer. The groups are involved 
in the cell cycle regulation; DNA replication and re-
pair; chromatin remodeling; chaperoning and signal 
transduction. The data permit to narrow down the 
field of further search for the non-canonical cancer-
related function of eEF1Bβ.
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Пошук неканонічних взаємодій β субодиниці комплексу 
елонгації трансляції eEF1B і аналіз їх можливої 
функціональної ролі
Л. М. Капустян, М. Дадлез, Б. С. Негруцький
Мета. Передбачити, до яких функціональних кластерів білків 
клітин карциноми легені А-549 може входити субодиниця β 
комплексу факторів елонгації трансляції eEF1B. Методи. 
Білки-партнери eEF1Bβ, отримані з цитоплазматичного екс-
тракту клітин А549 методом ко-імуно пре ци пі тації (co-IP), були 
ідентифіковані за допомогою высоко ефективної рідинної хро-
матографії з тандемною мас-спектрометрією (LC-MS/MS). 
Сітка молекулярних взаємодій eEF1Bβ була передбачена і по-
будована за допомогою програми Cytoscape 3.2.0 з використан-
ням плагіна MCODE. Результати. Методом мас-спектрометрії 
було ідентифіковано 162 білка, що взаємодіють з eEF1Bβ в ци-
топлазмі клітин карциноми легені A549. Можливі функціо-
нальні сітки, що включають ці контакти, були передбачені біо-
інформатично. Висновки. Чотири білкові сітки були ідентифі-
ковані як можливі мішені eEF1Bβ при раку. Ці групи білків за-
лучені в регуляцію клітинного циклу; реплікацію та репарацію 
ДНК, ремоделювання хроматину; шаперонну функцію та сиг-
нальну трансдукцію. Отриманні данні дозволяють звузити по-
ле подальшого пошуку неканонічних, пов’язаних з раком 
функцій eEF1Bβ.
К л юч ов і  с л ов а: eEF1Bβ, білок-білкові взаємодії, клітини 
A549.
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Поиск неканонических взаимодействий β субъединицы 
комплекса элонгации трансляции eEF1B и анализ их 
возможной функциональной роли
Л. Н. Капустян, М. Дадлез, Б. С. Негруцкий
Цель. Предсказать функциональные кластеры белков, в какие 
может быть вовлечена β субъединица комплекса факторов 
элонгации трансляции eEF1B в клетках карциномы легкого 
А549. Методы. Белки-партнёры eEF1Bβ, полученные из цито-
плазматического экстракта клеток А549 методом ко-иммуно-
преципитации (co-IP), были идентифицированы с помощью 
высокоэффективной жидкостной хроматографии и последую-
щей тандемной масс-спектрометрии (LC-MS/MS). Сеть моле-
кулярных взаимодействий eEF1Bβ была предсказана и постро-
ена с помощью программы Cytoscape 3.2.0 с использованием 
плагина MCODE. Результаты. Методом масс-спектрометрии 
было идентифицировано 162 белка, взаимодействующих с 
eEF1Bβ в цитоплазме клеток карциномы лёгкого A549. 
Возможные функциональные сети, включающие эти контак-
ты, были предсказаны биоинформатически. Выводы. Четыре 
белковые сети были идентифицированы в качестве возможных 
мишеней eEF1Bβ при раке. Эти группы белков вовлечены в 
регуляцию клеточного цикла; репликацию и реперацию ДНК, 
ремоделирование хроматина; шаперонную функцию и сиг-
нальную трансдукцию. Полученные данные позволяют сузить 
поле дальнейшего поиска неканонических, связанных с раком 
функций eEF1Bβ.
К л юч е в ы е  с л ов а: eEF1Bβ, белок-белковые взаимодей-
ствия, клетки A549.
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